A Randomized, Double-blind, Placebo-Controlled Trial of Subcutaneously Injected Apomorphine for Parkinsonian Off-State Events

2001240 citationsJournal Article

Authors

Richard B. Dewey · Nanotherapeutics (United States)

J. Thomas Hutton · Covenant Medical Center

Peter A. LeWitt · Center for Neurosciences

Stewart A. Factor · Albany Medical Center Hospital

Abstract

Apomorphine by intermittent subcutaneous injection is effective and safe for outpatient use to reverse off-state events that occur despite optimized oral therapy.

Topics & Keywords

Parkinson's Disease Mechanisms and Treatments Botulinum Toxin and Related Neurological Disorders Neurological disorders and treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Archives of Neurology

Volume 58, Issue 9, pp. 1385-1385

DOI: 10.1001/archneur.58.9.1385

Field-Weighted Citation Impact: 5.04